Literature DB >> 19139379

Reconsidering the roles of the mineralocorticoid receptor.

John W Funder1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139379     DOI: 10.1161/HYPERTENSIONAHA.108.119966

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  38 in total

Review 1.  The role of aldosterone in the metabolic syndrome.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

Review 2.  Transcriptional analysis of endocrine disruption using zebrafish and massively parallel sequencing.

Authors:  Michael E Baker; Gary Hardiman
Journal:  J Mol Endocrinol       Date:  2014-06       Impact factor: 5.098

Review 3.  Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease.

Authors:  Laura D Kubzansky; Gail K Adler
Journal:  Neurosci Biobehav Rev       Date:  2009-07-22       Impact factor: 8.989

Review 4.  Novel therapeutic targets for the treatment of heart failure.

Authors:  Juan Tamargo; José López-Sendón
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

5.  Mineralocorticoid-receptor antagonists in heart failure: a tale of serendipity and success.

Authors:  Alex Reyentovich; Stuart D Katz
Journal:  Curr Heart Fail Rep       Date:  2011-06

6.  Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.

Authors:  Luminita H Pojoga; Tham M Yao; Lauren A Opsasnick; Waleed T Siddiqui; Ossama M Reslan; Gail K Adler; Gordon H Williams; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-07-16       Impact factor: 4.030

7.  Aldosterone-receptor antagonists in heart failure: insights after EMPHASIS-HF.

Authors:  Miriam S Jacob; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2011-03

8.  Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.

Authors:  Luminita H Pojoga; Zuzana Adamová; Abhinav Kumar; Amanda K Stennett; Jose R Romero; Gail K Adler; Gordon H Williams; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

9.  The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.

Authors:  Daniel Lavall; Christian Selzer; Pia Schuster; Matthias Lenski; Oliver Adam; Hans-Joachim Schäfers; Michael Böhm; Ulrich Laufs
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

10.  Blockade of glucocorticoid receptors with RU486 attenuates cardiac damage and adipose tissue inflammation in a rat model of metabolic syndrome.

Authors:  Yuuri Takeshita; Shogo Watanabe; Takuya Hattori; Kai Nagasawa; Natsumi Matsuura; Keiji Takahashi; Toyoaki Murohara; Kohzo Nagata
Journal:  Hypertens Res       Date:  2015-07-09       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.